Antinociceptive and neuropharmacological activities of methanol extract of Phoenix sylvestris fruit pulp by Md. Shafiullah Shajib et al.
ORIGINAL RESEARCH
published: 02 October 2015
doi: 10.3389/fphar.2015.00212
Frontiers in Pharmacology | www.frontiersin.org 1 October 2015 | Volume 6 | Article 212
Edited by:
Adolfo Andrade-Cetto,
Universidad Nacional Autónoma de
México, Mexico
Reviewed by:
Keliang Xie,
General Hospital of Tianjin Medical
University, China
Jelena Cvejic,
University of Novi Sad, Serbia
*Correspondence:
Mohammad Zafar Imam,
Department of Pharmacy, Stamford
University Bangladesh, 51 Siddeswari
Road, Dhaka 1217, Bangladesh
zafarimam@gmail.com
Specialty section:
This article was submitted to
Ethnopharmacology,
a section of the journal
Frontiers in Pharmacology
Received: 21 July 2015
Accepted: 11 September 2015
Published: 02 October 2015
Citation:
Shajib MS, Akter S, Ahmed T and
Imam MZ (2015) Antinociceptive and
neuropharmacological activities of
methanol extract of Phoenix sylvestris
fruit pulp. Front. Pharmacol. 6:212.
doi: 10.3389/fphar.2015.00212
Antinociceptive and
neuropharmacological activities of
methanol extract of Phoenix
sylvestris fruit pulp
Md. Shafiullah Shajib 1, Saleha Akter 2, Tajnin Ahmed 1 and Mohammad Zafar Imam 1*
1Department of Pharmacy, Stamford University Bangladesh, Dhaka, Bangladesh, 2Department of Pharmacy, Primeasia
University, Dhaka, Bangladesh
Fruits of Phoenix sylvestris Roxb. (Arecaceae) are used to treat back pain, toothache,
headache, arthritis, nervous debility and as sedative. The aim of this study was to
evaluate the antinociceptive and neuropharmacological activities of methanol extract of
P. sylvestris fruit pulp (MEPS). The antinociceptive activity of MEPS was evaluated by
heat-induced (hot plate, tail immersion test) and chemical-induced pain models (acetic
acid-induced writhing, formalin-induced nociception, glutamate-induced nociception
and paw edema test). The effect of MEPS on central nervous system (CNS) was
studied using hole cross test, open field test, sodium thiopental-induced sleeping time
and elevated plus maze test. MEPS showed strong, significant and dose-dependent
antinociceptive activity in all heat-induced and chemical-induced pain models at all
experimental doses. Involvement of opioid receptor mediated analgesia was evident
from the reversal of analgesic effect by naloxone. MEPS also showed reduced locomotor
activity in both hole cross and open field tests. The increase in sleeping time in sodium
thiopental-induced sleeping test and anxiolytic activity in elevated plus maze test were
also significant. So, it is evident that MEPS possesses strong central and peripheral
antinociceptive activity as well as CNS depressant, sedative and anxiolytic activity. The
results justify the ethnomedicinal use of P. sylvestris fruit in different painful conditions
and CNS disorders.
Keywords: Phoenix sylvestris Roxb., Arecaceae, ethnomedicine, antinociceptive, CNS depressant, sedative,
anxiolytic
Abbreviations: MEPS, Methanol extract of Phoenix sylvestris fruit pulp; CNS, central nervous system; GC-MS, Gas
chromatography-mass spectroscopy; ACE, Angiotensin I-converting enzyme; r.p.m, Rotation per minute; AVMA, American
Veterinary Medical Association; icddr,b, International Center for Diarrhoeal Disease Research, Bangladesh; p.o, per oral, i.p.
intraperitoneal; NIST-MS, National Institute of Standards and Technology- mass spectroscopy; EI, electron ionization; TIC,
total ionic chromatogram; % MPE, percentage of maximal possible effect; MST, mean square traveled by animals; ANOVA,
analysis of variance; LD50, median lethal dose; COX, cycloxoygenase, LOX, lipoxygenase, TNF-α, Tumor necrosis factor alpha;
IL-1β, Interleukin-1 beta; IL-8, Interleukin 8; PGs, Prostaglandins; NMDA, N-methyl-D-aspartate; AMPA, Alpha-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; ROS,
Reactive oxygen species; NOS, Nitric oxide synthase; GAE, Gallic acid equivalence method; GABA, gamma amino butyric
acid; GBC, GABA/benzodiazepine/chloride complex; NLX, naloxone; ST, sodium thiopental; n, number of mice; RT, retention
time; PA, peak area; eV, electron volt.
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Introduction
Investigation of pharmacological basis of the therapeutic
uses of plants by traditional practitioners is an integral
part of ethnopharmacology (Leonti and Casu, 2013).
Ethnopharmacological knowledge continues to contribute
to the discovery of new antinociceptive agents from plants
(Calixto et al., 2000). Phytotherapy based on this knowledge
is also being used as a guide for the development of CNS
depressant, sedative, anxiolytic drugs (Gurib-Fakim, 2006).
Phoenix sylvestris Roxb. (Arecaceae), locally known as Khejur,
is a palm tree cultivated for its syrupy juice and edible fruit
in Bangladesh. Fruits of the plant are used to treat back pain,
stomachache, toothache, headache, arthritis, pain of buttocks,
fever, piles, nervous debility, and as nervine tonic, restorative,
sedative in ethnomedicine (Ghani, 2003; Acharya and Pokhrel,
2006; Harney, 2013; Manikandan, 2013). Besides, fruits are used
in cough, diarrhea, dysentery, opthalmia, opacity of cornea, and
toothworm (Ghani, 2003; Ahmad et al., 2008; Rajkumari et al.,
2013; Murthy and Madhav, 2015). Fruits are also employed as
aphrodisiac, cooling and gastric stimulant in traditional medicine
(Goswami et al., 2012; Sambandan and Dhatchanamoorthy,
2012). Amino acids (mainly alanine), vitamins A, B, and D,
sugars, tannins, mucilage and ascorbic acid have been found in
fruits (Ghani, 2003). Proanthocyanidin, a polyphenolic substance
belonging to the flavonoid group, has been isolated from the
fruits of P. sylvestris (Rao et al., 1980). The antioxidant activity of
fruits has been reported (Mukherjee et al., 2014). Aqueous extract
of the fruits has been found to inhib the angiotensin I-converting
enzyme (ACE), α-glucosidase and α-amylase (Das et al., 2012;
Das and De, 2013). The erythropoietic activity of the fruits has
also been reported (Lohar et al., 2009).
Ethnomedicinal reports on P. sylvestris fruits demonstrate
its extensive application in different painful conditions and
neurological disorders. However, there is lack of scientific
study regarding antinociceptive as well as neuropharmacological
activities of P. sylvestris fruits. Therefore, we aimed to investigate
the central and peripheral antinociceptive activities of P. sylvestris
fruit pulp using heat-induced (hot plate and tail immersion
test) and chemical-induced pain models (acetic acid-induced
writhing, formalin induced-licking and glutamate-induced paw
licking test). For the evaluation of neuropharmacological
activities we studied locomotor activity by open field and hole
cross method, sedative activity by sodium thiopental-induced
sleeping time test and anxiolytic activity by elevated plus maze
test. In addition, we have also reported the bioactive compounds
by gas chromatography-mass spectroscopy (GC-MS) analysis of
P. sylvestris fruit pulp.
Materials and Methods
Collection, Identification and Extraction of Plant
Material
Mature but unripe fruits of P. sylvestris were collected from
Akabpur,Mainamati, Comilla, Bangladesh in July 23, 2013. Fruits
were identified by Sarder Nasir Uddin, Senior Scientific Officer,
Bangladesh National Herbarium, Mirpur, Dhaka, Bangladesh.
A voucher specimen (DACB: 38499) has been deposited in
the herbarium for further reference. The pulp of the fruits
was separated from pit, dried and grounded. The powdered
pulp (230 g) was macerated using 1000mL of methanol with
occasional stirring at 25 ± 2◦C for 7 days. The extract was then
filtered using sterilized cotton filter and Buchner funnel. A rotary
evaporator was used to remove the solvent at 40◦ C and 50 r.p.m.
under reduced pressure. After removal of solvent, 30.19 g (yield
13.13 %) dried extract was obtained and this crude extract was
used for the experiments.
Ethical Statements
Ethical Principles and Guidelines of Scientific Experiments on
Animals (1995) formulated by The Swiss Academy of Medical
sciences and the Swiss Academy of Sciences were followed
for the care and treatment of the animals. All the procedures
and protocols were approved by the Ethics Committee of
StamfordUniversity Bangladesh (SUB/IAEC/13.02). The animals
were euthanized using pentobarbital in accordance with AVMA
guidelines for the Euthanasia of Animals: 2013 edition and
sufficient measures were taken to minimize suffering prior to,
during and after the experiments.
Animals
Swiss albino mice were collected from Animal Resources
Branch of International Centre for Diarrhoeal Disease Research,
Bangladesh (icddr,b). The animals were housed in 120 × 30 ×
30 cm cages and flake wood shavings were provided for
bedding. The health status of mice was checked by daily
monitoring during acclimatization period and before and after
experiments. The animals were provided with standard diet and
tap water ad libitum. For the period of 14 days animals were
acclimatized in the laboratory environment before experiments.
The animals were fasted overnight only before experiments.
The standard laboratory conditions (relative humidity 55–60%;
room temperature 25 ± 2◦C; 12 h light/dark cycle with lights
on at 7:00 a.m. and off at 7:00 p.m.) were maintained. Animals
weighing between 25–30 g and 8–10 weeks aged were used for the
experiments. All the experiments were performed between 9:00
a.m. and 5.00 p.m.
Drugs and Chemicals Used in the Experiments
The drugs and chemicals used in this study are: diclofenac
sodium (Novartis Bangladesh Ltd.), morphine sulfate, sodium
thiopental (Gonoshasthaya Pharmaceuticals Ltd.), diazepam
(Square Pharmaceuticals Ltd.), naloxone hydrochloride (Samarth
Life Sciences Pvt. Ltd., India), methanol, acetic acid, formalin,
L-glutamic acid (Merck, Germany).
Standard Drugs and Treatments
Physiological saline (0.9% sodium chloride) was used for the
preparation of all the standard drugs and MEPS doses. It was
used as vehicle at the dose of 10mL/kg for the control groups.
The doses (50, 150, 300, and 450mg/kg body weight) of MEPS
were selected on the basis of the effects of the trial dose and
previously reported effective analgesic doses of the methanol
extract of P. sylvestris (Howlader et al., 2006). The vehicle
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and MEPS were administered per oral (p.o) 30min before the
experiments. Morphine sulfate and diclofenac sodium were used
as standard drug at the dose of 5mg/kg and 10mg/kg respectively
in antinociceptive tests. Both of them were administered
intraperitoneally (i.p.) 15min before the experiments. In hot
plate and tail immersion test naloxone was employed (i.p.) 15min
before the administration of morphine sulfate or MEPS, at the
dose of 2mg/kg to evaluate opioid mediated antinociceptive
activity. Diazepam was used as standard drug in open field, hole
cross, sodium thiopental-induced sleeping time and elevated plus
maze test at the dose of 1mg/kg (i.p.). In sodium thiopental-
induced sleeping time and elevated plus maze test diazepam
was administered 30min prior to starting experiments. Sodium
thiopental was administered (i.p.) at the dose of 40mg/kg.
Preliminary Phytochemical Screening
The crude extract of P. sylvestris fruits was qualitatively tested
for phythochemicals using following reagents and chemicals:
Carbohydrates with Molisch’s and Fehling’s reagents, reducing
sugars with Benedict’s reagent, glycosides with aqueous NaOH,
glucosides with Fehling’s reagent and H2SO4, resins with acetic
anhydride and H2SO4, tannins with Ferric chloride and Lead
acetate, proteins with NaOH and Cu2SO4, saponins with stable
foam producing ability, flavonoids with the use of Zn and
HCl, alkaloids with Mayer’s, Hager’s, Wagner’s and Dragendroff’s
reagents and steroids with Libermann-Burchard’s reagent. The
change of color in respective tests was observed according to the
standard procedures to detect the chemical constituents (Ghani,
2005).
GC-MS (Gas Chromatography-mass
Spectroscopy) Analysis
The GC-MS analysis was performed using Agilent Technologies
7890A capillary gas chromatograph, directly coupled to a mass
spectrometer system (Model: 5975C inert XL EI/CI MSD with
triple axis detector). A fused silica capillary column of 5% phenyl,
95% dimethyl-poly-silloxane (HP-5MSI; length: 90 m, diameter:
0.250mm and film: 0.25µm) was used. The GC parameter
was set as follows: the inlet temperature was set at 250◦C and
oven temperature was programmed as 90◦C for 0min, then
3◦C/min to 200◦C for 2min and then 15◦C/min to 280◦C for
2min. Total run time was 46min and column flow rate was
1.1mL/min Helium gas. The auxiliary (GC to MS interface)
temperature was set to 280◦C. The MS parameter was set as the
MS was in scan mode. The ionization mode was EI (electron
ionization) type. The mass range was set in the range of 50–
550m/z. MS quad temperature and source temperature was set
at 150◦C and 230◦C respectively. Each component were searched
and identified by using “NIST-MS Library 2009.” Peak area
of the total ionic chromatogram (TIC) was used to determine
the relative percentage amounts of separated compounds and
calculation were done automatically.
Acute Toxicity Test
The acute toxicity of MEPS was observed in seven experimental
groups. Each group contained five animals (n = 5). The
experimental groups received MEPS at the dose of 500, 1000,
2000, 3000, 4000, 5000, and 6000mg/kg body weight (p.o). Each
group of animals were placed in separate cages and allowed
for free access of water ad libitum and food. The animals were
observed for the next 72 h to find anymortality, adverse reactions
like skin rashes, itching, swelling and behavioral changes (Walker
et al., 2008).
Experimental Procedures for Antinociceptive Test
Hot Plate Test
Hot plate test was performed using Eddy’s hot plate (Kshitij
Innovations, Haryana, India) for determining the central
analgesic activity of MEPS. The temperature of hot plate was
maintained at 55 ± 1◦C. A pre-treatment latency was recorded
as baseline for the study. Acute responses like jumping, forepaw
licking and withdrawal of paw(s) were considered as nociception.
After the treatment of mice with vehicle, MEPS (p.o) or standard
drug morphine (i.p.) the latency periods were recorded at 30, 45,
60, 90, and 120min (Eddy and Leimbach, 1953). The mice were
placed in hot plate not more than for 20 s to avoid any tissue
damage. The procedure was repeated by employing naloxone
(i.p.) 15min before morphine sulfate or MEPS administration
in mice for the evaluation of opioid receptor involvement and
the data were pooled. To determine the percentage of maximal
possible effect (% MPE) following formula was used (Coelho
et al., 2005):
% MPE =
Postdrug latency − predrug latency
Cutoff period − predrug latency
× 100
Tail Immersion Test
The procedure was carried out as previously reported (Janssen
et al., 1963). The temperature of the water bath was set constant
at 52± 1◦C. Mice that exerted deflection of tail from warm water
within 1.5–3.5 s were selected for the study. Mice were gently
immobilized for 25–30 s using “Chux” and 1–2 cm of their tail
was submersed into the warm water. The violent flick response
of mice was taken as end point of nociception. A cut off period
of 20 s was maintained to avoid injury to mice. The latency time
at 30, 45, 60, 90, and 120min following administration of vehicle,
morphine (i.p.) or MEPS were recorded. A pre-treatment latency
was obtained before administration. The same test was carried
out with the prior administration of naloxone (i.p.) as described
in hot plate test and % MPE was calculated from the latency
periods.
Acetic Acid-induced Writhing Test
The effect of MEPS against chemical induced central and
peripheral nociception was evaluated by performing acetic acid-
induced writhing test. To induce writhing, 0.7% acetic acid
(10mL/kg) was injected (i.p.) 30min after the administration of
vehicle or MEPS and 15min of diclofenac sodium treatment.
Mice were placed in box, left for 5min and then the number
of writhing was counted for the next 10min (Vogel, 2007). The
writhing was characterized by abdominal contraction, stretching
or bending of the body, trunk and/or pelvis ending with limbs
extension.
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Formalin-induced Licking Test
Formalin was injected in the sub-plantar region of the right hind
paw of mice to induce pain. Each mouse was injected with a
volume of 20µl of 1.35% formalin solution (0.5% formaldehyde)
made up in saline. Formalin was injected 30min after the
administration of vehicle or MEPS. The standard drug morphine
was injected 15min before the formalin injection. Right hind paw
licking of mice was measured from 0 to 5min as early phase
response (neurogenic phase) and from 15 to 25min as late phase
response (inflammatory phase). The licking was considered as
indicative of nociception (Coelho et al., 2005).
Glutamate-induced Paw Licking and Edema Test
The mice were treated with vehicle, MEPS or diclofenac sodium
first. The thickness of right hind paw of each mouse was
measured at this stage using digital slide calipers. Glutamate
was administered to the sub-plantar region of the right hind
paw of each mouse (20µL/20µmol per paw) 30min after the
administration of vehicle or MEPS and 15min after standard
drug treatment. To avoid irritation, pH of the preparation was
adjusted at 7.4. After glutamate challenge the mice were placed in
observation chambers. The licking of injected paw was counted
for 15min and paw thickness was measured again for each
mouse. The measure of paw thickness before glutamate injection
was subtracted from paw thickness after glutamate challenge to
determine the degree of edema (1) in mm (Rodrigues et al.,
2012).
Experimental Procedures for
Neruopharmacological Test
Open Field Test
Open field test was performed to evaluate effect of MEPS on
locomotion of mice. The experiment was performed in an
isolated, silent and dimly lit area. The dimension of apparatus
of open field was 50 × 50 × 50 cm3 in size. The floor of the
open field was divided into series of squares and each square were
alternatively colored black and white. Each mouse was placed at
the center of the field after the treatment with vehicle, diazepam
or MEPS. Then the number of squares traveled was counted for
3min at 0, 30, 60, 90, and 120min (Gupta et al., 1971). The %
inhibition was calculated by using the formula, where “MST”
means mean squares traveled:
% inhibition
=
MST by control group − MST by treatment group
MST by control group
× 100
Hole Cross Test
The hole cross test was performed as previously describe by
Takagi et al. (1971). A 30 × 20 × 14 cm3 size hole cross box was
used to perform the experiment. A fixed partition into the middle
of the box divided it into two compartments. There was a 3 cm
hole to make easy passage for mice in the partition. Mice were
treated with vehicle, diazepam or MEPS and immediately after
treatment mice were placed beside the wall of one compartment
facing to the hole. Then the number of movement from one
compartment to other through the hole was counted for a period
of 3min at 0, 30, 60, 90, and 120min. The % inhibition was
calculated from the number of movements.
Sodium Thiopental-induced Sleeping Time Test
Mice were treated with vehicle, diazepam or MEPS. To induce
sleep, sodium thiopental (40mg/kg) was administered to each
mouse 30min after the treatments and placed in an observation
chamber. After administration of sodium thiopental, time was
counted till loss of righting reflex and recorded as the latent
period. The duration of sleep was recorded from loss of righting
reflex to recovery of righting reflex (Ferrini et al., 1974).
Elevated Plus Maze Test
Elevated plus maze test was performed to evaluate the anxiolytic
effect of MEPS. The maze consisted of two open arms (50 ×
10 cm) and two enclosed arms (50× 10× 40 cm). The arms were
arranged such a way that each type was opposite to each other
and was elevated to 50 cm height above the floor. The experiment
was performed in an isolated and silent area. Vehicle, MEPS
or diazepam were administered 30min before the experiment.
Each mouse was placed individually in the center of the maze
facing a closed arm. Entry of four paws in an arm was defined
as arm entries (Pellow et al., 1985). Then the following parameter
was observed and counted: (a) number of entries, (b) time spent
into close and open arms during 5min observation period. The
percentage of time spent on open arm by each animal was
calculated as follows:
% of spent time =
Open arm time
Open arm time + Closed arm time
× 100
Statistical Analysis
The results were expressed as mean ± SEM (n = 5). To perform
statistical analysis of the results, One-Way analysis of variance
(ANOVA) followed by Dunnett’s post-hoc or Bonferroni test was
used as appropriate. All statistical analysis was performed by
SPSS 19 software. Differences between groups were considered
significant at the level of p < 0.05.
Results
Preliminary Phytochemical Screening
The presence of carbohydrates, reducing sugars, resins, tannins,
proteins, saponins, falvonoids, alkaloids, and steroids in MEPS
was found in the preliminary phytochemical screening.
GC-MS Analysis
The compounds identified by GC-MS analysis in MEPS are
listed in Table 1 and the chromatogram is shown in Figure 1.
Among 35, the major constituents were identified by comparing
the relative percentage amount and they are: 2,3-Dihydro-
3,5-dihydroxy-6-methyl-4H-pyran-4-one (14.24%), Catechol
(13.49%), n-Hexadecanoic acid (9.25%), Methyl oleate (6.81%),
Oleic acid (6.77%), 4-methylcatechol (5.92%), methyl palmitate
(4.84%), 1-Ethynyl-7-(2’-methyl-1’-propenyl) tricycloheptanes
(4.37%), Neophytadiene (4.03%), p-methoxyphenethyl alcohol
(3.93%), Squalene (3.44%), Linoleate (3.09%), Hexadecanoic
acid, 2-hydroxy-1-(hydroxymethyl) ethyl ester (2.87%), Lauric
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TABLE 1 | Compounds identified in MEPS by GC-MS analysis and their biological activity.
SL no. RT(min) % PA Compound Name Biological Activity References
01 6.191 1.71 Diethylnitrosamine Not found –
02 6.426 14.24 2, 3-Dihydro-3,
5-dihydroxy-6-methyl-4H-pyran-4-one
Antioxidant, autonomic nerve stimulator,
anti proliferative and pro-apoptotic
Ban et al., 2007; Beppu et al., 2012; Yu
et al., 2013
03 7.725 13.49 Catechol Anti inflammatory Zheng et al., 2008
04 10.488 5.92 4-methylcatechol Analgesic and anti-depressant, brain
derived neurotrophic factor stimulator,
antioxidant
Hanaoka et al., 1994; Jongberg et al.,
2011; Fukuhara et al., 2012
05 14.305 4.37 1-Ethynyl-7-(2’-methyl-1’-propenyl) tricyclo
heptanes
Not found –
06 16.502 3.99 p-methoxyphenethyl alcohol Bacteriostatic Khafagy and Lambooy, 1966
07 16.556 0.73 2,4-Di-tert-butylphenol Antioxidant Yoon et al., 2006
08 19.827 0.73 3,
4-dihydro-8-hydroxy-3-methyl-isocoumarin
Antioxidant, Fungicidal Schulz et al., 1995; Liu et al., 2007
09 20.519 2.50 Lauric acid Antimicrobial, anti inflammatory Nakatsuji et al., 2009
10 21.732 1.38 Diethyl Phthalate Not found –
11 22.350 0.83 Cyclopentane, 3-heptyl- Not found –
12 26.550 0.41 Methyl tetradecanoate Not found –
13 27.969 1.16 (-)-Loliolide Antidepressant, immunosuppressive Neergaard et al., 2010
14 30.595 4.03 Neophytadiene Antibacterial, anti inflammatory Mustapa et al., 2015
15 32.157 0.77 Hexadecane Not found –
16 33.599 4.84 methyl palmitate Anti inflammatory, antifibrotic El-Demerdash, 2011
17 34.818 9.25 n-Hexadecanoic acid Anti inflammatory Aparna et al., 2012
18 39.247 3.09 Methyl linoleate Not found –
19 39.436 6.81 Methyl oleate Not found –
21 39.745 2.05 Phytol Antinociceptive, antioxidant, anti
inflammatory, anticonvulsant, sedative,
anxiolytic
Costa et al., 2012, 2014; Santos et al.,
2013; Silva et al., 2013
22 40.111 1.08 Methyl stearate Not found –
23 40.248 0.88 Linoleic acid Anti inflammatory Zhao et al., 2005
24 40.380 6.77 Oleic acid Anti inflammatory Zhao et al., 2005
25 42.852 0.31 2-Butenenitrile, 2-chloro-3-
(4-methoxyphenyl)-
Not found –
26 43.035 0.37 2 (3H)- Furanone, dihydro-5-tetradecyl- Not found –
27 43.138 0.24 Methyl eicosanoate Not found –
28 43.252 0.41 Phosphine, chloromenthylphenyl- Not found –
29 43.813 3.44 Squalene Antioxidant Kim and Karadeniz, 2012
30 44.134 0.29 4-Dehydroxy-N- (4,
5-methylenedioxy-2-nitrobenzylidene)
tyramine
Not found –
31 44.597 0.59 Phenanthridinium, 5, 6-dimethyl-, iodide Not found –
32 44.763 0.33 -Cheilanth-12-enic Methyl Ester Not found –
33 44.843 0.33 Adamantane, 1-isothiocyanato-3-methyl Not found
34 44.900 2.87 Hexadecanoic acid,
2-hydroxy-1-(hydroxymethyl) ethyl ester
Not found –
35 45.066 0.65 Methyl docosanoate Not found –
SL, serial; RT, retention time; PA, peak area.
acid (2.50%), Phytol (2.05%), Ethanamine, N-ethyl-N-nitroso
(1.17%), (-)-Loliolide (1.16%).
Acute Toxicity
Oral administration of MEPS did not produce any toxicity at
doses of 500–6000mg/kg. During the 72 h observation period no
behavioral changes, allergic reaction or mortality were observed.
This result demonstrates that MEPS have lower toxicity profile.
Hot Plate Test
Oral administration of MEPS demonstrated significant increase
in latency period to thermal stimulus at the doses of 300 and
450mg/kg in hot plate test (p < 0.01) as shown in Table 2.
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FIGURE 1 | Total ionic chromatogram (TIC) of methanol extract of P. sylvestris fruit (MEPS). TIC of MEPS obtained by GC-MS with energy of ionization of 70
eV.
TABLE 2 | Effect of MEPS, morphine and reversal effect of naloxone in hot plate test.
Treatment Dose (mg/kg) Latency Period (sec) (%MPE)
Pre-treatment 30min 45min 60min 90min 120min
Vehicle – 3.32 ± 0.41 3.64 ± 0.39 3.71 ± 0.30 3.74 ± 0.42 3.82 ± 0.33 3.65 ± 0.40
Morphine 5 (i.p.) 3.02 ± 0.21 7.56 ± 0.75**
(26.80)
9.88 ± 0.39**
(40.22)
11.23 ± 0.77**
(48.36)
7.85 ± 0.38**
(28.39)
6.41 ± 0.51**
(19.81)
MEPS 50 3.20 ± 0.21 4.29 ± 0.27
(6.49)
5.02 ± 0.25
(10.75)
5.73 ± 0.40
(14.98)
5.42 ± 0.30
(13.13)
4.49 ± 0.35
(7.61)
MEPS 150 3.42 ± 0.30 5.17 ± 0.59
(10.59)
5.39 ± 0.45
(11.97)
6.05 ± 0.62
(16.01)
5.93 ± 0.97
(14.96)
5.57 ± 0.44
(12.81)
MEPS 300 3.38 ± 0.35 5.19 ± 0.44
(10.68)
5.53 ± 0.39
(12.71)
6.51 ± 0.40*
(18.57)
7.72 ± 0.34**
(26.01)
6.60 ± 0.28**
(19.23)
MEPS 450 3.33 ± 0.34 6.24 ± 0.17*
(17.28)
6.48 ± 0.47**
(18.70)
7.38 ± 0.69**
(24.00)
7.73 ± 0.54**
(26.37)
8.88 ± 0.55**
(33.37)
NLX 2 (i.p.) 3.21 ± 0.22 2.89 ± 0.16 2.74 ± 0.15 2.61 ± 0.16 2.81 ± 0.18 2.95 ± 0.28
NLX + Morphine 2+5 3.23 ± 0.11 3.58 ± 0.12a
(2.12)
3.24 ± 0.18a
(0.09)
3.05 ± 0.22a
(−1.05)
2.80 ± 0.14a
(−2.54)
3.07 ± 0.15a
(−0.92)
NLX + MEPS 2+50 3.28 ± 0.20 3.51 ± 0.17
(1.33)
3.11 ± 0.28
b (−1.03)
3.74 ± 0.34b
(2.71)
4.08 ± 0.40b
(4.74)
3.23 ± 0.47
(−0.29)
NLX + MEPS 2+150 3.24 ± 0.17 3.72 ± 0.22
(2.87)
3.15 ± 0.18
c(−0.57)
3.79 ± 0.30c
(3.28)
3.53 ± 0.22c
(1.70)
3.19 ± 0.24c
(−0.32)
NLX + MEPS 2+300 3.25 ± 0.34 3.81 ± 0.33
(3.39)
3.40 ± 0.22d
(0.86)
4.53 ±
0.50d (7.75)
4.95 ± 0.5d
(10.27)
4.24 ± 0.45d
(5.95)
NLX + MEPS 2+450 3.28 ± 0.20 3.93 ± 0.24e
(3.83)
4.17 ± 0.3e
(5.31)
4.55 ± 0.39e
(7.60)
3.39 ± 0.29e
(0.64)
3.25 ± 0.30e
(−0.21)
Each value is presented as mean ± SEM (n = 5), MEPS, Methanol extract of P. sylvestris fruit pulp; NLX, Naloxone.*p < 0.01, **p < 0.001 compared with the control group (Dunnett’s
test). ap < 0.001, bp < 0.05, cp < 0.05, dp < 0.01, ep < 0.01 compared with the morphine, MEPS 50, MEPS 150, MEPS 300, MEPS 450 group respectively (Bonferroni’s test).
The protection against heat-induced pain response of MEPS was
dose-dependent and stronger at 450mg/kg dose than other doses.
The reaction time for standard drug morphine was more than
any dose of MEPS at all observation period. MEPS also showed
significant % MPE at all experimental doses (p < 0.05). The
antinoceptive activity of MEPS at all four doses and of morphine
was significantly antagonized by naloxone (p < 0.05); (Table 2).
Tail Immersion Test
MEPS significantly reduced the hot-water induced nociception
at all experimental doses in tail immersion test (p < 0.001).
The antinociceptive effect of MEPS and morphine are shown in
Table 3. Both MEPS and morphine significantly increased the
latency time. The % MPE of the extract was also significant
at all experimental doses (p < 0.05). The % MPE value for
morphine was higher than MEPS at all observation periods.
The activity of MEPS against thermal nociception was dose-
dependent. Naloxone significantly reversed the antinoceptive
effect of morphine and of MEPS at all experimental doses (P <
0.01).0.1.
Acetic Acid-induced Writhing
As shown in Table 4, acetic acid-induced writhing response was
significantly decreased by standard drug (diclofenac sodium)
and MEPS at all doses (p < 0.001). The % inhibition of
writhing by MEPS was dose-dependent and highest at the dose
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TABLE 3 | Effect of MEPS, morphine and reversal effect of naloxone in tail immersion test.
Treatment Dose (mg/kg) Latency Period (s) (%MPE)
Pre-treatment 30min 45min 60min 90min 120min
Vehicle – 2.25 ± 0.11 2.55 ± 0.19 2.42 ± 0.11 2.56 ± 0.15 2.85 ± 0.31 2.86 ± 0.33
Morphine 5 (i.p.) 2.37 ± 0.15 8.88 ± 0.19*
(36.95)
9.43 ± 0.18*
(40.02)
10.60 ± 0.36*
(46.70)
8.35 ± 0.19*
(33.87)
4.34 ± 0.18*
(11.09)
MEPS 50 2.25 ± 0.19 2.81 ± 0.11
(3.16)
3.47 ± 0.12*
(6.83)
3.84 ± 0.11*
(8.93)
3.99 ± 0.17
(9.83)
3.45 ± 0.14
(6.75)
MEPS 150 2.49 ± 0.15 3.51 ± 0.12
(5.73)
4.04 ± 0.18*
(8.78)
4.39 ± 0.18*
(10.78)
4.90 ± 0.12*
(13.74)
3.98 ± 0.14
(8.48)
MEPS 300 2.74 ± 0.19 3.79± 0.15*
(6.09)
4.54 ± 0.12*
(10.37)
4.92 ± 0.12*
(12.58)
5.47 ± 0.12*
(15.84)
4.46 ± 0.14*
(9.93)
MEPS 450 2.56 ± 0.12 4.35 ± 0.13*
(10.24)
4.80 ± 0.16*
(12.83)
5.34 ± 0.14*
(15.96)
5.68 ± 0.13*
(17.90)
5.96 ± 0.12*
(19.46)
NLX 2 (i.p.) 2.58 ± 0.15 2.49 ± 0.19 2.48 ± 0.18 2.33 ± 0.17 2.54 ± 0.22 2.33 ± 0.18
NLX + Morphine 2+ 5 2.69 ± 0.18 2.86 ± 0.12a
(0.96)
2.55 ± 0.11a
(−0.83)
2.41 ± 0.14a
(−1.64)
2.60 ± 0.20a
(−0.55)
2.55 ± 0.18a
(−0.85)
NLX + MEPS 2+ 50 2.58 ± 0.13 3.04 ± 0.11
(2.48)
2.43 ± 0.16b
(−1.04)
2.39 ± 0.13b
(−1.22)
2.57 ± 0.14b
(−0.25)
3.27 ± 0.26
(3.29)
NLX + MEPS 2+ 150 2.74 ± 0.25 2.34 ± 0.12c
(−2.71)
2.52 ± 0.16c
(−1.64)
2.62 ± 0.19c
(−1.14)
2.69 ± 0.20c
(−0.73)
2.78 ± 0.15c
(0.52)
NLX + MEPS 2+ 300 2.71 ± 0.17 2.60 ± 0.28d
(−0.72)
2.42 ± 0.11d
(−1.72)
2.60 ± 0.17d
(−0.67)
2.91 ± 0.19d
(1.11)
2.58 ± 0.21d
(−0.79)
NLX + MEPS 2+ 450 2.76 ± 0.23 2.44 ± 0.14e
(−1.88)
2.67 ± 0.32e
(−0.53)
2.79 ± 0.34e
(0.22)
2.58 ± 0.13e
(−1.15)
2.99 ± 0.30e
(1.32)
Each value is presented as mean ± SEM (n = 5), MEPS = Methanol extract of P. sylvestris fruit pulp; NLX = Naloxone. *p < 0.001 compared with the control group (Dunnett’s test).
ap < 0.001, bp < 0.01, cp < 0.01, dp < 0.01, ep < 0.001 compared with the morphine, MEPS 50, MEPS 150, MEPS 300, MEPS 450 group respectively (Bonferroni’s test).
TABLE 4 | Effect of MEPS and diclofenac sodium in the acetic
acid-induced writhing test.
Treatment Dose (mg/kg) Number of Writhing % Inhibition
Vehicle – 34.1 ± 0.62 –
Diclofenac sodium 10 (i.p.) 6.80 ± 0.25* 80.05
MEPS 50 24.30 ± 1.10* 28.74
MEPS 150 21.20 ± 1.49* 37.83
MEPS 300 16.70 ± 0.97* 51.02
MEPS 450 12.50 ± 0.76* 63.34
Each value is presented as mean ± SEM (n = 5), MEPS, Methanol extract of P. sylvestris
fruit pulp. *p < 0.001 compared with the control group (Dunnett’s Test).
of 450mg/kg (63.34%). The standard drug (diclofenac sodium)
showed maximum % inhibition (80.05%).
Formalin-induced Licking
MEPS at the doses of 150, 300, and 450mg/kg and the
centrally acting analgesic, morphine, produced significant
inhibition of formalin-induced licking (p < 0.001) in
both early and late phase of formalin-induced licking test
(Table 5). The inhibition of licking by MEPS was dose-
dependent and percent of inhibition was highest at 450mg/kg
in both early and late phases (68.21% and 75.68% respectively).
Morphine completely inhibited the nociceptive effect at late
phase.
Glutamate-induced Paw Licking and Edema
MEPS significantly reduced the glutamate-induced paw licking at
the doses of 150, 300, and 450mg/kg (p < 0.001). The inhibitory
effect of MEPS was dose-dependent and highest at the dose
of 450mg/kg (47.71%). However, the standard drug (diclofenac
sodium) showed maximum inhibition (71.06%). The extract also
showed significant reduction of paw edema (p < 0.001) at all the
test doses (Table 6).
Open Field Test
MEPS significantly inhibited the locomotor activity at the doses
of 50 and 150mg/kg for first 60 and 90min respectively.
However, at the doses of 300 and 450mg/kg, MEPS significantly
reduced the locomotor activity from 30 to 120min like the
reference drug diazepam (p < 0.05). The percent inhibition of
the dose 450mg/kg was close to that of diazepam at 30 and 60min
(Table 7).
Hole Cross Test
MEPS demonstrated significant inhibition of movement at the
doses of 300 and 450mg/kg throughout the observation periods
in hole cross test (p < 0.05). On the other hand the dose
50 and 150mg/kg showed significant effect at later observation
periods. The standard drug diazepam showed significant (p <
0.05) reduction of movement and highest percent inhibition of
locomotion at all the study periods. The reduction of locomotor
activity by MEPS was dose-dependent (Table 8).
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TABLE 5 | Effect of MEPS and morphine in formalin-induced paw licking test.
Treatment Dose (mg/kg) Licking time (sec) of the hind paw
Early phase (0–5min) % inhibition Late phase (15–25min) % inhibition
Vehicle – 132.13 ± 4.45 – 153.16 ± 4.71 –
Morphine 5 (i.p.) 36.73 ± 5.09* 72.20 0.00 ± 0.00* 100.00
MEPS 50 110.76 ± 5.99** 16.18 109.06 ± 5.81* 28.79
MEPS 150 75.99 ± 6.57* 42.49 69.99 ± 5.70* 54.30
MEPS 300 59.18 ± 5.13* 55.21 54.16 ± 3.22* 64.64
MEPS 450 42.01 ± 5.15* 68.21 37.24 ± 3.39* 75.68
Each value is presented as mean ± SEM (n = 5), MEPS, Methanol extract of P. sylvestris fruit pulp. *p < 0.001, **p < 0.05 compared with the control group (Dunnett’s Test).
TABLE 6 | Effect of MEPS and diclofenac sodium in glutamate-induced paw licking and edema test.
Treatment Dose (mg/kg) Licking time (s) % Inhibition (1) Paw thickness (mm) % Inhibition
Vehicle – 205.74 ± 3.73 – 1.38 ± 0.04 –
Diclofenac sodium 10 (i.p.) 59.54 ± 4.14* 71.06 0.49 ± 0.06* 64.24
MEPS 50 186.32 ± 3.85** 9.43 0.87 ± 0.07* 36.77
MEPS 150 147.83 ± 3.43* 28.14 0.85 ± 0.04* 38.23
MEPS 300 119.47 ± 6.73* 41.93 0.79 ± 0.02* 42.15
MEPS 450 107.58 ± 3.39* 47.71 0.73 ± 0.05* 46.66
Each value is presented as mean ± SEM (n = 5), MEPS, Methanol extract of P. sylvestris fruit pulp. *p < 0.001, **p < 0.05 compared with the control group (Dunnett’s Test).
TABLE 7 | Effect of MEPS and diazepam in open field test.
Treatment Dose (mg/kg) Number of square crossed (% inhibition)
0min 30min 60min 90min 120min
Vehicle – 85.40 ± 2.94 68.20 ± 4.05 56.40 ± 2.67 38.80 ± 2.46 33.20 ± 2.59
Diazepam 1 (i.p.) 84.40 ± 2.16 35.40 ± 1.86* (48.09) 28.80 ± 3.29* (48.93) 17.60 ± 3.34* (54.64) 18.40 ± 1.16* (44.58)
MEPS 50 86.80 ± 5.50 50.80 ± 4.24* (25.51) 37.40 ± 2.38* (33.69) 32.80 ± 1.56 (15.46) 27.20 ± 1.15 (18.07)
MEPS 150 88.20 ± 5.24 41.80 ± 2.46* (38.71) 33.00 ± 3.86* (41.49) 24.40 ± 2.50* (37.11) 24.80 ± 2.72 (25.30)
MEPS 300 86.60 ± 3.93 38.40 ± 1.96* (43.69) 30.20 ± 2.15* (46.45) 23.40 ± 1.29* (39.69) 22.80 ± 4.05* (31.32)
MEPS 450 88.80 ± 5.95 36.80 ± 2.92* (46.04) 28.20 ± 2.08* (50.00) 18.40 ± 1.16* (52.58) 15.40 ± 1.43* (53.61)
Each value is presented as mean ± SEM (n = 5), MEPS, Methanol extract of P. sylvestris fruit pulp. *p < 0.05 compared with the control group (Dunnett’s Test).
TABLE 8 | Effect of MEPS and diazepam in hole cross test.
Treatment Dose (mg/kg) Number of hole crossed (% inhibition)
0min 30min 60min 90min 120min
Vehicle – 14.20 ± 0.58 11.00 ± 0.95 9.00 ± 0.54 8.60 ± 0.68 8.00 ± 0.45
Diazepam 1 (i.p.) 13.80 ± 0.86 5.40 ± 0.68* (50.91) 2.80 ± 0.37* (68.89) 2.00 ± 0.44* (76.74) 1.40 ± 0.24* (82.50)
MEPS 50 13.20 ± 0.86 9.60 ± 0.98 (12.73) 7.20 ± 0.73 (20.00) 6.40 ± 0.81* (25.58) 5.80 ± 0.73* (27.50)
MEPS 150 14.40 ± 1.07 9.40 ± 0.51 (14.74) 6.40 ± 0.51* (28.89) 4.80 ± 0.58 (44.19) 4.40 ± 0.51* (45.00)
MEPS 300 13.20 ± 0.91 8.00 ± 0.32* (27.27) 5.20 ± 0.37* (42.22) 4.00 ± 0.32* (53.49) 3.40 ± 0.51* (57.50)
MEPS 450 13.40 ± 0.74 7.20 ± 0.49* (34.54) 4.80 ± 0.66* (46.67) 3.20 ± 0.58* (62.79) 2.60 ± 0.68* (67.75)
Each value is presented as mean ± SEM (n = 5), MEPS, Methanol extract of P. sylvestris fruit pulp. *p < 0.05 compared with the control group (Dunnett’s Test).
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TABLE 9 | Effect of MEPS and diazepam in sodium thiopental-induced
sleeping time test.
Treatment Dose (mg/kg) Onset of Sleep (s) Duration of Sleep (min)
Vehicle + ST – 190.94 ± 1.27 32.09 ± 1.14
Diazepam + ST 1+ 40 93.93 ± 3.05* 96.34 ± 2.09*
MEPS + ST 50+ 40 174.31 ± 4.49** 40.01 ± 1.11**
MEPS + ST 150+ 40 156.6 ± 2.31* 50.67 ± 1.30*
MEPS + ST 300+ 40 103.83 ± 5.74* 71.30 ± 1.81*
MEPS + ST 450+ 40 92.15 ± 5.02* 88.73 ± 4.48*
Each value is presented as mean ± SEM (n = 5), MEPS, Methanol extract of P. sylvestris
fruit pulp; ST, sodium thiopental.*p < 0.001, **p < 0.05 compared with the control group
(Dunnett’s Test).
Sodium Thiopental-induced Sleeping Time Test
The doses 150, 300, and 450mg/kg of MEPS showed significant
(p < 0.001) reduction in onset of sleep and increased sleep
duration. The dose 50mg/kg also increased the sleeping time and
decreased onset of sleep (p < 0.05). The dose-dependent effect
of MEPS was clear from the observations of 50–450mg/kg doses.
The effect of diazepam was found most significant considering
the onset of sleeping and highest duration of sleeping (p < 0.001)
(Table 9).
Elevated Plus Maze Test
Table 10 clearly shows that the time spent in open arm was
increased and the percent of time spent was significant (p < 0.05)
at all the doses of MEPS in elevated plus maze test. The standard
drug diazepam also significantly increased the percent time spent
in open arm (p < 0.05). The percent open arm entries of MEPS
at the doses of 150, 300, and 450mg/kg and of diazepam were
significant (p < 0.05). In addition, total number of entries was
also reduced significantly by the extract and diazepam compared
to the control group.
Discussion
The results of the present study indicate peripheral and central
antinociceptive, CNS depressant, sedative and anxiolytic effect of
MEPS at different doses in mice models. In addition, study of
acute toxicity at the doses of 500–6000mg/kg suggests that MEPS
possess low toxicity profile.
The significant (p < 0.01) inhibition of the thermally
induced nociception and increase of latency time in hot plate
test demonstrates the central antinociceptive activity of MEPS
(Table 2). The effect was also observed (p < 0.001) in the
tail immersion test (Table 3). The tail withdrawal response is
selective only for centrally acting analgesics (Srinivasan et al.,
2003). Therefore, the outcome of tail immersion test supports
the effect of MEPS in hot plate test. The hot plate test induces
nociception via supraspinal reflex whereas tail immersion test
induce nociceptive pain by spinal reflexes (Chapman et al.,
1985). Opioid agents exhibit their analgesic effect via both
supraspinal (µ1, κ3, δ1, σ2) and spinal (µ2, κ1, δ2) receptors
(Hosseinzadeh et al., 2002; Jinsmaa et al., 2004, 2005). Therefore
the antinociceptive activity of MEPS is due to action on spinal
and supraspinal receptors. Naloxone significantly antagonized
(p < 0.05) the antinociceptive effect of morphine and MEPS at
different doses level in both thermal pain models. This confirms
the opioid receptors mediated antinociceptive activity of MEPS.
Acetic acid-induced writhing test is a commonly used method
to evaluate the antinociceptive activity of peripheral and central
analgesic agents. The action of acetic acid causes the release
of endogenous histamine, prostaglandins (PGs), serotonin,
bradykinin, cycloxoygenase (COX), lipoxygenase (LOX), and
cytokines (TNF-α, IL-1β, and IL-8). These visceral inflammatory
mediators enter the dorsal horn of central nervous system and
stimulate primary afferent nociceptors (Ikeda et al., 2001) and
results in induction of pain expressing abdominal constriction
(Bley et al., 1998). Oral administration of MEPS (p < 0.001)
significantly reduced the number of abdominal constriction
induced by acetic acid in mice (Table 4). The result clearly
indicates that the antinociception produced by MEPS is due to
its inhibition of COX, LOX and other endogenous inflammatory
mediators as well as of primary afferent nociceptors signal
transduction. The identified compound phytol has been reported
to give antinociceptive activity via central and peripheral
mechanisms (Santos et al., 2013). Besides histamine, serotonin,
bradykinin, PGE2 and cytokines inhibitory activity of phytol
(Silva et al., 2013) provide justification of the result.
The formalin-induced nociception is mediated via direct
stimulation of sensory afferent fibers by the chemical nociceptors
especially C-fibers in early phase and peripheral inflammatory
mediators such as histamine, prostaglandins (PGs), serotonin
and bradykinin in late phase (Le Bars et al., 2001; Parada
et al., 2001). In formalin-induced licking test peripherally
acting analgesics inhibit early phase nociception where the
centrally acting analgesics inhibit the nociception of both phases
(Hunskaar and Hole, 1987; Tjølsen et al., 1992). The results
showed that MEPS significantly (p < 0.001) reduced paw licking
at both early and late phases in a dose-dependent manner.
The effect was stronger in late phase (Table 5). Therefore the
inhibition of nociception by MEPS in both phases gives further
evidence of its central antinociceptive effect. Moreover, the late
phase inhibition suggests the anti-inflammatory potential of
MEPS.
MEPS produced significant dose-dependent inhibition (p <
0.001) in both glutamate-induced paw licking and edema
(Table 6). The glutamate induced nociceptive response and
edema formation involves (N-methyl-D-aspartate) NMDA
and non-NMDA (AMPA, Kainate) receptors respectively in
peripheral, spinal and supraspinal sites of action. Glutamate
causes neuropeptides (substance P) and pro-inflammatory
cytokines (TNF- α, IL-1β) release to transmit nociceptive signals
from the peripheral nervous system to the dorsal horn of
the spinal cord. Moreover, the pro-inflammatory signals are
mediated by, ROS (Reactive oxygen species) and NOS (Nitric
oxide synthase) participated stimulation of TNF- α, IL-1,
and IL-6 genes through the activation of the redox-sensitive
transcription factor NF-κB (Beauparlant and Hiscott, 1996;
Beirith et al., 2002; Ribas et al., 2008). Therefore, from the
results it can be suggested that MEPS inhibited the release
of neuropeptides and activation of NMDA and non-NMDA
receptors as well as interrupted the ROS and NOS mediated
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TABLE 10 | Effect of MEPS and diazepam in elevated plus maze test.
Treatment Dose (mg/kg) Open arm time (s) % Open arm time (s) Open arm entries % open arm entries Total arm entries
Vehicle – 39.05± 5.92 16.31± 2.40 6.20± 1.39 31.81± 3.46 22± 2.34
Diazepam 1 164.98± 6.50 64.25± 1.43* 10.80± 1.49 67.58± 2.09* 12.6± 1.21*
MEPS 50 100.32± 6.01 40.12± 1.76* 6.80± 1.31 37.07± 6.62 16.4± 1.66
MEPS 150 106.83± 6.32 43.56± 1.83* 8.00± 1.40 53.48± 5.98** 15.4± 0.93**
MEPS 300 138.87± 14.72 52.02± 5.47* 9.20± 1.35 55.27± 5.91* 15.8± 0.80**
MEPS 450 136.62± 18.39 54.43± 6.21* 11.4± 1.75 63.48± 4.70* 15± 1.51**
Each value is presented as mean ± SEM (n = 5), MEPS, Methanol Extract of P. sylvestris fruit pulp. *p < 0.01, **p < 0.05 compared with the control group (Dunnett’s Test).
pro-inflammatory signals. The compounds such as 2,3-Dihydro-
3,5-dihydroxy-6-methyl-4H-pyran-4-one, catechol, oleic acid
and linoleic acids found in MEPS has been reported to inhibit
the NF-κB, NOS, TNF-α, and TNF-α gene expression respectively
(Zhao et al., 2005; Ban et al., 2007; Zheng et al., 2008) which
strongly suggests the pro-inflammatory signal inhibitory activity
of MEPS.
We have detected the presence of carbohydrates, steroids,
alkaloids, saponins, and tannins by preliminary phytochemical
screening and considerable amount of phenolic content (128.6±
2.7 mgGAE/g) has been found in P. sylvestris fruit (Prakash
et al., 2013). Scientific investigations reported that plant materials
containing flavonoids, phenols and tannins are responsible for
analgesic and CNS activity (Takahashi et al., 1986; Starec et al.,
1988; Mills and Bone, 2000; Morteza-Semnani et al., 2006).
Beside antinociceptive activity, MEPS has also been found
to have neurobehavioral effects. Both in open field and hole
cross test MEPS depressed the central nervous system. The
locomotor activity of mice gradually decreased during the period
of observation (Tables 7, 8). In addition, MEPS significantly
decreased latency time and increased the sleeping time in sodium
thiopental-induced sleeping time test (Table 9) suggesting its
possible sedative effect. CNS depressant and sedative drugs
potentiate the gamma aminobutyric acid (GABA) mediated post
synaptic inhibition via allosteric modification of GABA receptors
as well as decrease the sleep latency and increase sleeping
time (Sieghart and Sperk, 2002; Aladeokin and Umukoro, 2011;
O’Donnell and Shelton, 2011). Therefore the significant decrease
of locomotion and sleep enhancement activity of MEPS reveals
its potential action on GABA receptors. The GABAA receptor
mediated sedative activity of identified compound phytol (Costa
et al., 2014) provides further evidence of GABAergic mechanism
of action of MEPS.
Another potentiality of MEPS was revealed in elevated plus
maze test. This test is frequently used to evaluate the anxiolytic or
anxiogenic properties of drug. The fact is rodents are extremely
aversive to an open area and the major index of anxiety is the
frequency and time spent in the open arms (Pellow and File,
1986). The benzodiazepine drugs exert their anxiolytic activity via
their action on GABA/benzodiazepine/chloride (GBC) complex
mechanism and increase the percent of spent time, frequency
of entries in open arm and also reduce total number of entries
(Pellow et al., 1985; Stephens et al., 1986). The results showed
that diazepam and MEPS significantly (p < 0.05) increased
percentage of spent time, frequency of entries in open arm and
reduced total arm entries in elevated plus maze (Table 10). The
findings of probable GABAergic-like mechanism of MEPS and
action like reference anxiolytic drug diazepammay be a potential
indicator of its anxiolytic-like activity. In addition the anxiolytic
effect of phytol (Costa et al., 2014) found in MEPS support our
results. Therefore the outcomes of our investigation rationalize
the traditional implication of P. sylvestris fruit as nervine tonic in
the treatment of CNS disorder like nervous debility.
From the results of different pain models it may be suggested
that crude methanol extract of P. sylvestris fruit possesses
potent and long-lasting antinociceptive activity. Inhibition of
MEPS-induced antinociception by selective opioid antagonist,
naloxone, suggests the involvement of opioid receptor mediated
analgesia. The results also provide the evidence of inhibition of
peripheral inflammatory mediators such as COX, LOX, PGs in
pain inhibition. In addition the neuropharmacological evaluation
also suggests the sleep enhancing and anxiolytic potentiality
of P. sylvestris fruit which is possibly mediated via GABAergic
pathway. These outcomes rationalize the use of P. sylvestris fruit
in traditional medicine in painful conditions such as toothache,
headache, arthritis backache or pain in buttocks, and also to
induce sedation, as nervine tonic and in the treatment of
nervous debility. The GC-MS analysis shows there are potential
biologically active compounds present in P. sylvestris fruit. Taking
the findings into account, it seems quite possible that P. sylvestris
fruit may lead to the development of new natural products having
analgesic and neuropharmacological effect.
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